|
|
 Previous Article | Table of Contents | Next Article 
Mobilization of long-term hematopoietic reconstituting cells in mice by the
combination of stem cell factor plus granulocyte colony-stimulating factor
XQ Yan, R Briddell, C Hartley, G Stoney, B Samal and I McNiece
Department of Developmental Hematology, Amgen Inc, Thousand Oaks, CA
91320-1789.
In this study, we have compared the ability of recombinant human
granulocyte colony-stimulating factor (rhG-CSF) alone and the combination
of low doses of recombinant rat pegylated stem cell factor (rrSCF-PEG) plus
rhG-CSF to mobilize peripheral blood progenitor cells (PBPCs) with
long-term engrafting potential. Female recipient irradiated mice were
transplanted with PBPCs from male mice that were mobilized with rhG-CSF
alone (group A) or rrSCF-PEG plus rhG-CSF (group B). As previously shown,
greater short-term survival resulted in group B compared with group A, with
80% and 40% survival at 30 days posttransplant, respectively. Both groups
of animals showed long-term donor-derived engraftment in greater than 95%
of animals, as determined by quantitative specific polymerase chain
reaction amplification of a Y chromosome sequence from whole blood of the
mice at 6 to 12 months posttransplantation. Analysis of individual
granulocyte-macrophage colonies, picked up from semisolid methylcellulose
culture of bone marrow cells from transplanted mice, resulted in detection
of donor- derived DNA in 98% of colonies from group B mice compared with
81% from group A mice. These data show that cells with long-term potential
are mobilized by rhG-CSF alone and the combination of rrSCF-PEG plus rhG-
CSF. Furthermore, an increased number of cells with short-term and long-
term engraftment potential was obtained with rrSCF-PEG plus rhG-CSF
compared with rhG-CSF alone.
Volume 84,
Issue 3,
pp. 795-799,
08/01/1994
Copyright © 1994 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Xie, M. Wu, R. Song, J. Ma, Y. Shi, W. Qin, and Y. Jin
A glucocorticoid amplifies IL-2-induced selective expansion of CD4+CD25+FOXP3+ regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation
Acta Biochim Biophys Sin,
September 1, 2009;
41(9):
781 - 791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. Haider and M. Ashraf
Bone marrow stem cell transplantation for cardiac repair
Am J Physiol Heart Circ Physiol,
June 1, 2005;
288(6):
H2557 - H2567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hematti, S. E. Sellers, B. A. Agricola, M. E. Metzger, R. E. Donahue, and C. E. Dunbar
Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates
Blood,
March 15, 2003;
101(6):
2199 - 2205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. King, D. Horowitz, S. B. Dillon, R. Levin, A. M. Farese, T. J. MacVittie, and L. M. Pelus
Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRO{beta}
Blood,
March 15, 2001;
97(6):
1534 - 1542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Shpall, C. A. Wheeler, S. A. Turner, S. Yanovich, R. A. Brown, A. L. Pecora, T. C. Shea, K. F. Mangan, S. F. Williams, C. F. LeMaistre, et al.
A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients
Blood,
April 15, 1999;
93(8):
2491 - 2501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F.M. Pruijt, Y. van Kooyk, C. G. Figdor, I. J.D. Lindley, R. Willemze, and W. E. Fibbe
Anti-LFA-1 Blocking Antibodies Prevent Mobilization of Hematopoietic Progenitor Cells Induced by Interleukin-8
Blood,
June 1, 1998;
91(11):
4099 - 4105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Limon, J. Briones, T. Puig, M. Carmona, O. Fornas, J. A. Cancelas, M. Nadal, J. Garcia, F. Rueda, and J. Barquinero
High-Titer Retroviral Vectors Containing the Enhanced Green Fluorescent Protein Gene for Efficient Expression in Hematopoietic Cells
Blood,
November 1, 1997;
90(9):
3316 - 3321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Raftopoulos, M. Ward, P. Leboulch, and A. Bank
Long-Term Transfer and Expression of the Human beta -Globin Gene in a Mouse Transplant Model
Blood,
November 1, 1997;
90(9):
3414 - 3422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Papayannopoulou, B. Nakamoto, R. G. Andrews, S. D. Lyman, and M. Y. Lee
In Vivo Effects of Flt3/Flk2 Ligand on Mobilization of Hematopoietic Progenitors in Primates and Potent Synergistic Enhancement With Granulocyte Colony-Stimulating Factor
Blood,
July 15, 1997;
90(2):
620 - 629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Morrison, D. E. Wright, and I. L. Weissman
Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization
PNAS,
March 4, 1997;
94(5):
1908 - 1913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
